Oluyemi Okupe sold $8.0M of HIMS
Chief Financial Officer at Hims & Hers Health, Inc.. 145,000 shares at an average of $55.35, traded Sep 15, 2025, filed Sep 17, 2025.
Score components
- +22RoleCFO
- +25Trade size$8.0M at market
- +20Share of holdings soldSold 53% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -1.1%, 3m -30.5%, 6m -54.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001773751-25-000300, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 15, 2025 | MOption exercise Class A Common Stock10b5-1 | +105,199 | - | - | 222,005 | Sep 17, 2025 |
| Sep 15, 2025 | FTax withholding Class A Common Stock10b5-1 | -58,021 | $53.96 | $3.1M | 163,984 | Sep 17, 2025 |
| Sep 15, 2025 | MOption exercise Class A Common Stock10b5-1 | +110,000 | $5.01 | $551k | 273,984 | Sep 17, 2025 |
| Sep 15, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -117,792 | $55.25 | $6.5M | 156,192 | Sep 17, 2025 |
| Sep 15, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -27,208 | $55.79 | $1.5M | 128,984 | Sep 17, 2025 |
| Sep 15, 2025 | MOption exercise Restricted Stock Unitderivative10b5-1 | -52,395 | $0.00 | $0 | 104,791 | Sep 17, 2025 |
| Sep 15, 2025 | MOption exercise Restricted Stock Unitderivative10b5-1 | -18,334 | $0.00 | $0 | 110,007 | Sep 17, 2025 |
| Sep 15, 2025 | MOption exercise Restricted Stock Unitderivative10b5-1 | -22,988 | $0.00 | $0 | 229,881 | Sep 17, 2025 |
| Sep 15, 2025 | MOption exercise Restricted Stock Unitderivative10b5-1 | -11,482 | $0.00 | $0 | 160,755 | Sep 17, 2025 |
| Sep 15, 2025 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -110,000 | $0.00 | $0 | 239,784 | Sep 17, 2025 |
Related signals
Other insiders at Hims & Hers Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $101k 3,461 shares | -1% | |
| 17Weak | Hims & Hers Health, Inc. | Oluyemi Okupe Chief Financial Officer | $59k 2,000 shares | -1% | |
| 30Weak | Hims & Hers Health, Inc. | Oluyemi Okupe Chief Financial Officer | $877k 29,277 shares | -11% | |
| 32Weak | Hims & Hers Health, Inc. | Oluyemi Okupe Chief Financial Officer | $355k 12,313 shares | -5% | |
| 21Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $174k 6,236 shares | -2% | |
| 31Weak | Hims & Hers Health, Inc. | Michael Chi Chief Operating Officer | $398k 14,027 shares | -3% | |
| 23Weak | Hims & Hers Health, Inc. | Mohamed Elshenawy CTO | $226k 7,954 shares | -4% | |
| 20Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $98k 3,458 shares | -1% | |
| 37Weak | Hims & Hers Health, Inc. | Deborah M. Autor Chief Policy Officer | $467k 16,773 shares | -26% | |
| 31Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $692k 25,111 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.